Table 2 Follow-up
N (%) | Median months; IQR | Median % PSMA primary tumour | PSMA 0–10% | PSMA >10% | Chi2 PSMA ≤10% vs >10% | |
|---|---|---|---|---|---|---|
Patients | 110 | 23 | 87 | |||
Follow-up (median months; IQR) | 57; 26–100 | 50; 13–96 | 63; 27–110 | |||
Locoregional recurrence | ||||||
Yes | 29 (26%) | 39; 20–91 | 40% | 9 | 20 | p = .12 |
No | 81 (74%) | 30% | 14 | 67 | ||
Distant metastasis | ||||||
Yes | 36 (33%) | 33; 12–77 | 38% | 7 | 29 | p = .79 |
No | 74 (67%) | 30% | 16 | 58 | ||
aLocoregional recurrence-free @ 10 years | ||||||
Yes | 84 (76%) | 35% | 14 | 70 | p = .05 | |
No | 26 (24%) | 31% | 9 | 17 | ||